ArriVent BioPharma, Inc.
AVBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001868279
No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.60B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in ArriVent BioPharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- +53 vs. Q4 2023
- Shares held
- 21.9M
- +21.9M vs. Q4 2023
- Total value
- $388.9M
- +$388.9M vs. Q4 2023
- New holders
- 53
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.60B |
| Q1 2026 | 139 | $969.5M |
| Q4 2025 | 122 | $810.3M |
| Q3 2025 | 106 | $712.4M |
| Q2 2025 | 99 | $732.0M |
| Q1 2025 | 83 | $539.3M |
| Q4 2024 | 80 | $757.5M |
| Q3 2024 | 68 | $612.3M |
| Q2 2024 | 54 | $404.2M |
| Q1 2024 | 53 | $388.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding ArriVent BioPharma, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 369 | $7.00K | 0.00% | +369 | New |
| Amalgamated Bank | 540 | $10.0K | 0.00% | +540 | New |
| Metropolitan Life Insurance Co | 567 | $10.1K | 0.00% | +567 | New |
| Tower Research Capital LLC (TRC) | 604 | $10.8K | 0.00% | +604 | New |
| Legal & General Group Plc | 896 | $16.1K | 0.00% | +896 | New |
| Ameritas Investment Partners, Inc. | 981 | $17.5K | 0.00% | +981 | New |
| California State Teachers Retirement System | 989 | $17.7K | 0.00% | +989 | New |
| STRS Ohio | 1,700 | $30.0K | 0.00% | +1,700 | New |
| Citigroup Inc | 1,741 | $31.1K | 0.00% | +1,741 | New |
| Bank of America Corp | 2,259 | $40.3K | 0.00% | +2,259 | New |
| Wells Fargo & Company | 3,231 | $57.7K | 0.00% | +3,231 | New |
| Cubist Systematic Strategies, LLC | 4,360 | $77.9K | 0.00% | +4,360 | New |
| BNP Paribas Arbitrage, SA | 4,659 | $83.2K | 0.00% | +4,659 | New |
| American International Group, Inc. | 4,845 | $86.5K | 0.00% | +4,845 | New |
| MetLife Investment Management | 5,514 | $98.5K | 0.00% | +5,514 | New |
| Rhumbline Advisers | 9,765 | $174.4K | 0.00% | +9,765 | New |
| UBS Group AG | 9,895 | $176.7K | 0.00% | +9,895 | New |
| JPMorgan Chase & Co | 12,556 | $224.3K | 0.00% | +12,556 | New |
| Nuveen Asset Management, LLC | 12,932 | $231.0K | 0.00% | +12,932 | New |
| Barclays PLC | 14,208 | $253.8K | 0.00% | +14,208 | New |
| Morgan Stanley | 21,141 | $377.6K | 0.00% | +21,141 | New |
| Point72 (DIFC) Ltd | 21,890 | $390.9K | 0.03% | +21,890 | New |
| Bank of New York Mellon Corp | 22,707 | $405.5K | 0.00% | +22,707 | New |
| Blackstone Group Inc. | 25,000 | $446.5K | 0.00% | +25,000 | New |
| Walleye Capital LLC | 25,000 | $446.5K | 0.00% | +25,000 | New |
| UBS Oconnor LLC | 26,181 | $467.6K | 0.01% | +26,181 | New |
| Point72 Asset Management, L.P. | 28,900 | $516.2K | 0.00% | +28,900 | New |
| MYDA Advisors LLC | 30,000 | $535.8K | 0.19% | +30,000 | New |
| Jane Street Group, LLC | 36,959 | $660.1K | 0.00% | +36,959 | New |
| Ghisallo Capital Management LLC | 50,000 | $893.0K | 0.10% | +50,000 | New |
| Charles Schwab Investment Management Inc | 77,760 | $1.39M | 0.00% | +77,760 | New |
| Northern Trust Corp | 78,409 | $1.40M | 0.00% | +78,409 | New |
| AlphaCentric Advisors LLC | 83,000 | $1.48M | 0.89% | +83,000 | New |
| Woodline Partners LP | 100,000 | $1.79M | 0.02% | +100,000 | New |
| State Street Corp | 122,264 | $2.18M | 0.00% | +122,264 | New |
| Farallon Capital Management, L.L.C. | 151,768 | $2.71M | 0.02% | +151,768 | New |
| Millennium Management LLC | 211,689 | $3.78M | 0.00% | +211,689 | New |
| Geode Capital Management, LLC | 225,049 | $4.02M | 0.00% | +225,049 | New |
| Citadel Advisors LLC | 286,512 | $5.12M | 0.00% | +286,512 | New |
| Perceptive Advisors LLC | 415,000 | $7.41M | 0.13% | +415,000 | New |
| Cormorant Asset Management, LP | 515,000 | $9.20M | 0.41% | +515,000 | New |
| Altitude Crest Partners Inc. | 555,555 | $9.92M | 4.25% | +555,555 | New |
| SC China Holding Ltd | 663,308 | $10.5M | 0.97% | +663,308 | New |
| Vanguard Group Inc | 648,735 | $11.6M | 0.00% | +648,735 | New |
| BlackRock Inc. | 654,804 | $11.7M | 0.00% | +654,804 | New |
| Novo Holdings A/S | 1,077,140 | $19.2M | 1.33% | +1,077,140 | New |
| General Catalyst Group Management, LLC | 1,494,786 | $26.7M | 2.05% | +1,494,786 | New |
| Suvretta Capital Management, LLC | 1,563,709 | $27.9M | 1.18% | +1,563,709 | New |
| Sofinnova Investments, Inc. | 1,696,752 | $30.3M | 1.79% | +1,696,752 | New |
| Octagon Capital Advisors LP | 1,943,836 | $34.7M | 4.22% | +1,943,836 | New |
| FMR LLC | 1,950,034 | $34.8M | 0.00% | +1,950,034 | New |
| OrbiMed Advisors LLC | 3,027,328 | $54.1M | 1.06% | +3,027,328 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 3,929,117 | $70.2M | 1.52% | +3,929,117 | New |